In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
24. January 2014
Page Content
Name
Novo A/S
Relation/category of close relation
Novo A/S is closely related to the chairman of Novozymes' board of directors, Henrik Gürtler
Trading date
January 22, 2014
Market
Nasdaq OMX Copenhagen A/S
Character of transaction
Sale of shares
Volume of transaction buy(+)/ sell (-)
-60,000
Value of transaction (DKK)
14,447,868.00 DKK
Name
Novo A/S
Relation/category of close relation
Novo A/S is closely related to the chairman of Novozymes' board of directors, Henrik Gürtler
Trading date
January 23, 2014
Market
Nasdaq OMX Copenhagen A/S
Character of transaction
Sale of shares
Volume of transaction buy(+)/ sell (-)
-100,000
Value of transaction (DKK)
23,828,130.00 DKK
This sale has been completed according to earlier communicated intention by Novo A/S to keep its relative holding of Novozymes B shares at the level it held prior to Novozymes' cancellation of B shares on 5 April 2013 (Company announcement no. 50, August, 2011).
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows:
- industry of cleaning and household maintenance products (28.5%);
- bioenergy (24.8%);
- food industry and human health (22.1%);
- technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries;
- agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods.
Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
NOVONESIS A/S 
By 
